Nanobiotix
Nanobiotix[edit | edit source]
Nanobiotix is a nanomedicine company that focuses on the development of nanoparticles for cancer treatment. The company is known for its innovative approach to enhancing the efficacy of radiotherapy using its proprietary technology.
History[edit | edit source]
Nanobiotix was founded in 2003 and is headquartered in Paris, France. The company was established with the aim of leveraging nanotechnology to improve cancer treatment outcomes. Over the years, Nanobiotix has developed a range of products that utilize nanoparticles to enhance the effects of traditional cancer therapies.
Technology[edit | edit source]
The core technology of Nanobiotix involves the use of nanoparticles to increase the effectiveness of radiotherapy. These nanoparticles are designed to accumulate in tumor tissues and amplify the radiation dose received by the cancer cells, thereby increasing the likelihood of destroying the tumor while minimizing damage to surrounding healthy tissues.
Nanoparticles in Radiotherapy[edit | edit source]
Nanobiotix's nanoparticles are engineered to interact with X-rays used in radiotherapy. When these nanoparticles are exposed to radiation, they produce secondary electrons that cause additional damage to the cancer cells. This process enhances the therapeutic index of radiotherapy, potentially allowing for lower doses of radiation to achieve the same or better therapeutic outcomes.
Products[edit | edit source]
Nanobiotix has developed several products based on its nanoparticle technology. The most notable product is NBTXR3, which is designed to be injected directly into tumors. NBTXR3 is currently being evaluated in clinical trials for various types of cancer, including head and neck cancer, liver cancer, and prostate cancer.
Clinical Trials[edit | edit source]
Nanobiotix is actively involved in clinical trials to assess the safety and efficacy of its products. These trials are conducted in collaboration with leading cancer research centers and hospitals around the world. The results of these trials will determine the future applications of Nanobiotix's technology in cancer treatment.
Future Directions[edit | edit source]
The future of Nanobiotix lies in expanding the applications of its nanoparticle technology beyond radiotherapy. The company is exploring the potential of its technology in combination with other cancer treatments, such as immunotherapy and chemotherapy.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
